Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#21
JOURNAL ARTICLE
Paula M Williams, Robert H Pratt, William L Walker, Sandy F Price, Rebekah J Stewart, Pei-Jean I Feng
After 27 years of declining U.S. tuberculosis (TB) case counts, the number of TB cases declined considerably in 2020, coinciding with the COVID-19 pandemic. For this analysis, TB case counts were obtained from the National TB Surveillance System. U.S. Census Bureau population estimates were used to calculate rates overall, by jurisdiction, birth origin, race and ethnicity, and age group. Since 2020, TB case counts and rates have increased each year. During 2023, a total of 9,615 TB cases were provisionally reported by the 50 U...
March 28, 2024: MMWR. Morbidity and Mortality Weekly Report
#22
JOURNAL ARTICLE
Samantha L Williams, Dallas J Smith, Kaitlin Benedict, Jamie R Ahlers, Connie Austin, Rachael Birn, Angel M Carter, Natalie N Christophe, Katie Cibulskas, Paul R Cieslak, Suzanne N Gibbons-Burgener, Michael Gosciminski, Malia J Ireland, Katelyn V Lazenby, Tom Loftus, Kristy Lunquest, Abby A Mathewson, Alyssa D Nguyen, Hanna N Oltean, BreAnne Osborn, Erin M Petro, Danny J Power, Rebecca R Reik, Levi Schlosser, Judi Sedivy, Chad B Smelser, Tom Chiller, Mitsuru Toda
Coccidioidomycosis, histoplasmosis, and blastomycosis are lower respiratory tract fungal infections whose signs and symptoms can resemble those of other respiratory illnesses, including pneumonia caused by bacterial or viral etiologies; this overlap in clinical presentation might lead to missed or delayed diagnoses. The causative fungi live in the environment, often in soil or plant matter. To describe the epidemiologic characteristics of cases of coccidioidomycosis, histoplasmosis, and blastomycosis during the COVID-19 pandemic, CDC analyzed case surveillance data for 2019-2021...
March 21, 2024: MMWR. Morbidity and Mortality Weekly Report
#23
JOURNAL ARTICLE
Alison Ruprecht, Mona Marin, Anna K Strain, Katie Harry, Cynthia Kenyon
No abstract text is available yet for this article.
March 21, 2024: MMWR. Morbidity and Mortality Weekly Report
#24
JOURNAL ARTICLE
Aderonke S Ajiboye, Stephanie O'Connor, Jonathan P Smith, Sevim Ahmedov, William L Coggin, Macarthur Charles, Smita Ghosh, Paul Pierre, Neha Shah, Richard A Teran, Patrick K Moonan, Anand Date
Tuberculosis (TB) is the leading cause of death among persons with HIV. In 2022, an estimated 167,000 TB-related deaths occurred globally among persons with HIV. TB preventive treatment (TPT) helps prevent TB disease and is recommended for persons at high risk for developing TB, including those with HIV. TPT, when taken with antiretroviral treatment (ART), can reduce TB-attributable deaths among persons with HIV. In 2018, the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) program committed to offer one course of TPT to all eligible clients receiving ART...
March 21, 2024: MMWR. Morbidity and Mortality Weekly Report
#25
JOURNAL ARTICLE
Anna R Yousaf, Katherine N Lindsey, Michael J Wu, Ami B Shah, Rebecca J Free, Regina M Simeone, Laura D Zambrano, Angela P Campbell
No abstract text is available yet for this article.
March 14, 2024: MMWR. Morbidity and Mortality Weekly Report
#26
JOURNAL ARTICLE
Kelley Bemis, Mabel Frias, Sheila Giovanni, Tarek Shackour, Heather D Reid, Jodi Morgan, Michael TeKippe, Demian Christiansen
No abstract text is available yet for this article.
March 14, 2024: MMWR. Morbidity and Mortality Weekly Report
#27
(no author information available yet)
No abstract text is available yet for this article.
March 14, 2024: MMWR. Morbidity and Mortality Weekly Report
#28
JOURNAL ARTICLE
Heather Demorest, Rachel Hinnenkamp, Maggie Cook-Shimanek, Alyssa N Troeschel, Michael Yeh, Thao-Phuong Christy Hallett, David Kuai, Johnni Daniel, Andrea Winquist
During March-April 2023, a total of 51 persons reported mild to severe gastrointestinal illness after eating at restaurant A in Bozeman, Montana. The outbreak resulted in multiple severe outcomes, including three hospitalizations and two deaths. After an inspection and temporary restaurant closure, the Montana Department of Public Health and Human Services and Montana's Gallatin City-County Health Department collaborated with CDC to conduct a matched case-control study among restaurant patrons to help identify the source of the outbreak...
March 14, 2024: MMWR. Morbidity and Mortality Weekly Report
#29
JOURNAL ARTICLE
Heidi L Moline, Ayzsa Tannis, Ariana P Toepfer, John V Williams, Julie A Boom, Janet A Englund, Natasha B Halasa, Mary Allen Staat, Geoffrey A Weinberg, Rangaraj Selvarangan, Marian G Michaels, Leila C Sahni, Eileen J Klein, Laura S Stewart, Elizabeth P Schlaudecker, Peter G Szilagyi, Jennifer E Schuster, Leah Goldstein, Samar Musa, Pedro A Piedra, Danielle M Zerr, Kristina A Betters, Chelsea Rohlfs, Christina Albertin, Dithi Banerjee, Erin R McKeever, Casey Kalman, Benjamin R Clopper, Meredith L McMorrow, Fatimah S Dawood
Respiratory syncytial virus (RSV) is the leading cause of hospitalization among infants in the United States. In August 2023, CDC's Advisory Committee on Immunization Practices recommended nirsevimab, a long-acting monoclonal antibody, for infants aged <8 months to protect against RSV-associated lower respiratory tract infection during their first RSV season and for children aged 8-19 months at increased risk for severe RSV disease. In phase 3 clinical trials, nirsevimab efficacy against RSV-associated lower respiratory tract infection with hospitalization was 81% (95% CI = 62%-90%) through 150 days after receipt; post-introduction effectiveness has not been assessed in the United States...
March 7, 2024: MMWR. Morbidity and Mortality Weekly Report
#30
JOURNAL ARTICLE
Machell Town, Paul Eke, Guixiang Zhao, Craig W Thomas, Jason Hsia, Carol Pierannunzi, Karen Hacker
Social determinants of health (SDOH) are a broad array of social and contextual conditions where persons are born, live, learn, work, play, worship, and age that influence their physical and mental wellbeing and quality of life. Using 2022 Behavioral Risk Factor Surveillance System data, this study assessed measures of adverse SDOH and health-related social needs (HRSN) among U.S. adult populations. Measures included life satisfaction, social and emotional support, social isolation or loneliness, employment stability, food stability/security, housing stability/security, utility stability/security, transportation access, mental well-being, and health care access...
March 7, 2024: MMWR. Morbidity and Mortality Weekly Report
#31
JOURNAL ARTICLE
Ahlia Sekkarie, Jing Fang, Donald Hayes, Fleetwood Loustalot
Hypertension, or high blood pressure, is a major risk factor for heart disease and stroke. It increases with age and is highest among non-Hispanic Black or African American persons, men, persons aged ≥65 years, those of lower socioeconomic status, and those who live in the southern United States. Hypertension affects approximately one half of U.S. adults, and approximately one quarter of those persons have their blood pressure under control. Reducing population-level hypertension prevalence and improving control is a national priority...
March 7, 2024: MMWR. Morbidity and Mortality Weekly Report
#32
JOURNAL ARTICLE
Devin I Freeman, Jennifer N Lind, Nina J Weidle, Andrew I Geller, Nimalie D Stone, Maribeth C Lovegrove
No abstract text is available yet for this article.
March 7, 2024: MMWR. Morbidity and Mortality Weekly Report
#33
JOURNAL ARTICLE
Shaveta Khosla, Marina Del Rios, Pavitra Kotini-Shah, Joseph Weber, Terry Vanden Hoek
Approximately 1,000 out-of-hospital cardiac arrests (OHCAs) are assessed by emergency medical services in the United States every day, and approximately 90% of patients do not survive, leading to substantial years of potential life lost (YPLL). Chicago emergency medical services data were used to assess changes in mean age and YPLL from nontraumatic OHCA in adults in biennial cycles during 2014-2021. Among 21,070 reported nontraumatic OHCAs during 2014-2021, approximately 60% occurred among men and 57% among non-Hispanic Black or African American (Black) persons...
March 7, 2024: MMWR. Morbidity and Mortality Weekly Report
#34
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
February 29, 2024: MMWR. Morbidity and Mortality Weekly Report
#35
JOURNAL ARTICLE
Sophie Zhu, Joshua Quint, Tomás M León, Monica Sun, Nancy J Li, Mark W Tenforde, Seema Jain, Robert Schechter, Cora Hoover, Erin L Murray
Surveillance data can provide rapid, within-season influenza vaccine effectiveness (VE) estimates to guide public health recommendations. Mandatory reporting of influenza vaccine administration to California's immunization information registry began January 1, 2023, and mandatory reporting of all influenza laboratory test results, including negative results, was instituted in California on June 15, 2023. These data, collected by the California Department of Public Health during October 1, 2023-January 31, 2024, were used to calculate interim influenza VE against laboratory-confirmed influenza by comparing the odds of vaccination among case-patients (persons who received a positive influenza laboratory test result) and control patients (those who received a negative influenza laboratory test result)...
February 29, 2024: MMWR. Morbidity and Mortality Weekly Report
#36
JOURNAL ARTICLE
Jennifer DeCuir, Amanda B Payne, Wesley H Self, Elizabeth A K Rowley, Kristin Dascomb, Malini B DeSilva, Stephanie A Irving, Shaun J Grannis, Toan C Ong, Nicola P Klein, Zachary A Weber, Sarah E Reese, Sarah W Ball, Michelle A Barron, Allison L Naleway, Brian E Dixon, Inih Essien, Daniel Bride, Karthik Natarajan, Bruce Fireman, Ami B Shah, Erica Okwuazi, Ryan Wiegand, Yuwei Zhu, Adam S Lauring, Emily T Martin, Manjusha Gaglani, Ithan D Peltan, Samuel M Brown, Adit A Ginde, Nicholas M Mohr, Kevin W Gibbs, David N Hager, Matthew Prekker, Amira Mohamed, Vasisht Srinivasan, Jay S Steingrub, Akram Khan, Laurence W Busse, Abhijit Duggal, Jennifer G Wilson, Steven Y Chang, Christopher Mallow, Jennie H Kwon, Matthew C Exline, Cristie Columbus, Ivana A Vaughn, Basmah Safdar, Jarrod M Mosier, Estelle S Harris, Jonathan D Casey, James D Chappell, Carlos G Grijalva, Sydney A Swan, Cassandra Johnson, Nathaniel M Lewis, Sascha Ellington, Katherine Adams, Mark W Tenforde, Clinton R Paden, Fatimah S Dawood, Katherine E Fleming-Dutra, Diya Surie, Ruth Link-Gelles
In September 2023, CDC's Advisory Committee on Immunization Practices recommended updated 2023-2024 (monovalent XBB.1.5) COVID-19 vaccination for all persons aged ≥6 months to prevent COVID-19, including severe disease. However, few estimates of updated vaccine effectiveness (VE) against medically attended illness are available. This analysis evaluated VE of an updated COVID-19 vaccine dose against COVID-19-associated emergency department (ED) or urgent care (UC) encounters and hospitalization among immunocompetent adults aged ≥18 years during September 2023-January 2024 using a test-negative, case-control design with data from two CDC VE networks...
February 29, 2024: MMWR. Morbidity and Mortality Weekly Report
#37
JOURNAL ARTICLE
Aaron M Frutos, Ashley M Price, Elizabeth Harker, Emily L Reeves, Haris M Ahmad, Vel Murugan, Emily T Martin, Stacey House, Elie A Saade, Richard K Zimmerman, Manjusha Gaglani, Karen J Wernli, Emmanuel B Walter, Marian G Michaels, Mary A Staat, Geoffrey A Weinberg, Rangaraj Selvarangan, Julie A Boom, Eileen J Klein, Natasha B Halasa, Adit A Ginde, Kevin W Gibbs, Yuwei Zhu, Wesley H Self, Sara Y Tartof, Nicola P Klein, Kristin Dascomb, Malini B DeSilva, Zachary A Weber, Duck-Hye Yang, Sarah W Ball, Diya Surie, Jennifer DeCuir, Fatimah S Dawood, Heidi L Moline, Ariana P Toepfer, Benjamin R Clopper, Ruth Link-Gelles, Amanda B Payne, Jessie R Chung, Brendan Flannery, Nathaniel M Lewis, Samantha M Olson, Katherine Adams, Mark W Tenforde, Shikha Garg, Lisa A Grohskopf, Carrie Reed, Sascha Ellington
In the United States, annual influenza vaccination is recommended for all persons aged ≥6 months. Using data from four vaccine effectiveness (VE) networks during the 2023-24 influenza season, interim influenza VE was estimated among patients aged ≥6 months with acute respiratory illness-associated medical encounters using a test-negative case-control study design. Among children and adolescents aged 6 months-17 years, VE against influenza-associated outpatient visits ranged from 59% to 67% and against influenza-associated hospitalization ranged from 52% to 61%...
February 29, 2024: MMWR. Morbidity and Mortality Weekly Report
#38
JOURNAL ARTICLE
Marissa B Esser, Adam Sherk, Yong Liu, Timothy S Naimi
Deaths from causes fully attributable to alcohol use have increased during the past 2 decades in the United States, particularly from 2019 to 2020, concurrent with the onset of the COVID-19 pandemic. However, previous studies of trends have not assessed underlying causes of deaths that are partially attributable to alcohol use, such as injuries or certain types of cancer. CDC's Alcohol-Related Disease Impact application was used to estimate the average annual number and age-standardized rate of deaths from excessive alcohol use in the United States based on 58 alcohol-related causes of death during three periods (2016-2017, 2018-2019, and 2020-2021)...
February 29, 2024: MMWR. Morbidity and Mortality Weekly Report
#39
JOURNAL ARTICLE
Alan C Ou, Laura A Zimmerman, James P Alexander, Natasha S Crowcroft, Patrick M O'Connor, Jennifer K Knapp
Rubella virus is a leading cause of vaccine-preventable birth defects. Infection during pregnancy can result in miscarriage, fetal death, stillbirth, or a constellation of birth defects, including cataracts, deafness, heart defects, and developmental delay, known as congenital rubella syndrome (CRS). A single dose of rubella-containing vaccine can provide lifelong protection against rubella. The Global Vaccine Action Plan 2011-2020 included a target to achieve elimination of rubella in at least five of the six World Health Organization (WHO) regions by 2020, and rubella elimination is a critical goal of the Immunization Agenda 2030...
February 29, 2024: MMWR. Morbidity and Mortality Weekly Report
#40
JOURNAL ARTICLE
Samantha D Swisher, Sara J Taetzsch, Mark E Laughlin, William L Walker, Adam J Langer, Tyler C Thacker, Jessica L Rinsky, Kimberly A Lehman, Anne Taffe, Nancy Burton, Doris M Bravo, Emily McDonald, Clive M Brown, Emily G Pieracci
Nonhuman primates (NHP) can become infected with the same species of Mycobacteria that cause human tuberculosis. All NHP imported into the United States are quarantined and screened for tuberculosis; no confirmed cases of tuberculosis were diagnosed among NHP during CDC-mandated quarantine during 2013-2020. In February 2023, an outbreak of tuberculosis caused by Mycobacterium orygis was detected in a group of 540 cynomolgus macaques (Macaca fascicularis) imported to the United States from Southeast Asia for research purposes...
February 22, 2024: MMWR. Morbidity and Mortality Weekly Report
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
